Marshall Wace, LLP Zoetis Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 812,727 shares of ZTS stock, worth $133 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

812,727

Previous 835,684 2.75%

Holding current value

$133 Million

Previous $145 Million 9.61%

% of portfolio

0.21%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $3.96 Million - $4.51 Million	-22,957 Reduced 2.75%	812,727 $159 Million
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $120 Million - $148 Million	824,843 Added 7608.55%	835,684 $145 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $1.32 Million - $1.59 Million	7,941 Added 273.83%	10,841 $1.83 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $25.8 Million - $34 Million	-170,135 Reduced 98.32%	2,900 $572,000
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $13.5 Million - $15.5 Million	80,598 Added 87.19%	173,035 $30.1 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $14.9 Million - $17.2 Million	92,437 New	92,437 $15.9 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $81 Million - $97.3 Million	-617,751 Reduced 98.42%	9,899 $1.45 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $55.8 Million - $68.7 Million	376,546 Added 149.96%	627,650 $93.1 Million
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $54.3 Million - $69.7 Million	-348,437 Reduced 58.12%	251,104 $43.2 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $98.5 Million - $127 Million	-543,252 Reduced 47.54%	599,541 $113 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $105 Million - $134 Million	541,656 Added 90.11%	1,142,793 $279 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $66.3 Million - $73.4 Million	-350,148 Reduced 36.81%	601,137 $117 Million
Q2 2021 Aug 13, 2021	SELL	$155.9 - $187.99 $120 Million - $144 Million	-767,090 Reduced 44.64%	951,285 $177 Million
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $165 Million - $194 Million	-1,146,524 Reduced 40.02%	1,718,375 $271 Million
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $88.7 Million - $98.5 Million	564,851 Added 24.56%	2,864,899 $474 Million
Q3 2020 Nov 16, 2020	BUY	$137.1 - $165.37 $25.4 Million - $30.6 Million	185,264 Added 8.76%	2,300,048 $380 Million
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $45.3 Million - $57.7 Million	404,604 Added 23.66%	2,114,784 $290 Million
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $89.4 Million - $140 Million	-964,501 Reduced 36.06%	1,710,180 $201 Million
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $63.1 Million - $72.3 Million	542,744 Added 25.46%	2,674,681 $354 Million
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $31 Million - $35.3 Million	-275,138 Reduced 11.43%	2,131,937 $266 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $90.1 Million - $105 Million	-919,152 Reduced 27.63%	2,407,075 $273 Million
Q1 2019 May 14, 2019	SELL	$81.56 - $100.67 $23.3 Million - $28.8 Million	-285,613 Reduced 7.91%	3,326,227 $335 Million
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $31.3 Million - $37.7 Million	395,267 Added 12.29%	3,611,840 $309 Million
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $116 Million - $130 Million	1,393,397 Added 76.43%	3,216,573 $295 Million
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $56.1 Million - $62.6 Million	701,801 Added 62.58%	1,823,176 $155 Million
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $6.35 Million - $7.52 Million	-88,760 Reduced 7.33%	1,121,375 $93.6 Million
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $66.1 Million - $76.1 Million	-1,045,493 Reduced 46.35%	1,210,135 $87.2 Million
Q3 2017 Nov 13, 2017	BUY	$59.73 - $65.4 $135 Million - $148 Million	2,255,628	2,255,628 $144 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Zoetis Inc. Transaction History